Adenovirus 5 HIV-1 gag vaccine (MSD)

N/A

Report date: 2024/12/11 10:05:06

Base Information

Drug NameAdenovirus 5 HIV-1 gag vaccine (MSD)

Drug Alias NameN/A

ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesMerck Sharp & Dohme Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMerck Sharp & Dohme Corp

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A